In the BioHarmony Drug Report Database

"Preview" Icon

Eslicarbazepine

Aptiom, Zebinix (eslicarbazepine) is a small molecule pharmaceutical. Eslicarbazepine was first approved as Aptiom on 2009-04-21. It has been approved in Europe to treat epilepsy. Aptiom’s patents are valid until 2032-08-24 (FDA).

 

Trade Name

 

Zebinix
 

Common Name

 

eslicarbazepine
 

ChEMBL ID

 

CHEMBL315985
 

Indication

 

epilepsy
 

Drug Class

 

Tricyclic compounds

Image (chem structure or protein)

Eslicarbazepine structure rendering